Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: arnold silver who wrote (509)	1/31/2004 12:28:21 PM
From: Jibacoa	Respond to of 3722

I am chicken and I will sell it at the open ,Monday. Arnie: I won't blame you for taking profits. The stock at present seems overbought and it hasn't closed the upgap on Jan.29 so there is some good probability that it may retest the support around the 3.30 level.<g> Several actions have been taken against them. I suppose you are referring to Dec.2000 when Representative John D. Dingell,the then Ranking Member of the Committee on Commerce wrote to Arthur Levitt,who was the Chairman of the SEC concerning "alleged violations of the federal securities laws in connection with a major stock scam involving Hemispherx Biopharma".<g> J.D.Dingell had previosly written in November 2000, to David M. Walker,who was the Comptroller of the GAO, concerning "an alleged fraudulent scheme in the stock of Hemispherx Biopharma".<g> Asensio & Company,had announced that Hemispherx was under investigation by the SEC for securities fraud. The company sued Ascencio,but on Feb 2002, a jury in Pennsylvania failed to return a verdict in its favor against Manuel Asensio and his company. During the trial Asensio's counter claims against the Company were withdrawn with prejudice. As you may remember,HEB's stock showed some volatility in 2000 when it more than doubled in February (8.8 to 18.5) to tank in March (19 to 9.75)<g> In Oct.2002 HEB's shares rose sharply (from $0.74 to $2.70)when the Taglich Brothers upgraded their rating to "buy" from "speculative buy" and increased the "target" to $25 within 36 months from their previous "target" of $13.75 Since then, the stock traded for a while at $1.33 in March and April last year and the higuest level is the $4.33 that it traded yesterday. But of course the "36 months" from Oct.2002 aren't over as yet.<g> Bernard